# Novavax (NVAX) — News NVAX · NASDAQ · Stock Canonical page: https://www.lighthorse.io/tickers/nvax/news ## Recent headlines - [Mahindra to sell 51% stake in Novavayu Aerospace to Embraer](https://www.ainvest.com/news/mahindra-sell-51-stake-novavayu-aerospace-embraer-2610) — AInvest Wire, Oct 9, 2026 Mahindra Group has announced plans to divest its 51% stake in Novavayu Aerospace to Embraer, a Brazilian aerospace manufacturer, as part of a strategic realignment of its portfolio . The transaction, which is subject to regulatory approvals, reflects Mahindra’s focus on optimizing capital… - [Mabion SA - Deal covers implementation and provision of analytical services for Novavax's early-stage pipeline projects](https://www.ainvest.com/news/mabion-sa-deal-covers-implementation-provision-analytical-services-novavax-early-stage-pipeline-projects-2609) — AInvest Wire, Sep 14, 2026 - [Mabion SA - Signs statement of work #12 with Novavax to expand cooperation under existing manufacturing agreement](https://www.ainvest.com/news/mabion-sa-signs-statement-work-12-novavax-expand-cooperation-existing-manufacturing-agreement-2609) — AInvest Wire, Sep 14, 2026 Mabion SA has signed Statement of Work #12 with Novavax, Inc., further expanding their strategic cooperation under the existing manufacturing agreement. The new work statement builds on the companies’ ongoing collaboration, which has previously supported the production of Novavax’s vaccine… - **Important** — [U.S. stocks close lower; Nasdaq drops 1.03%, Dow falls 0.79%, S&P 500 loses 0.71%. Crypto and optical stocks slide.](https://www.ainvest.com/news/stocks-close-nasdaq-drops-1-03-dow-falls-0-79-500-loses-0-71-crypto-optical-stocks-slide-2609) — AInvest Wire, Sep 1, 2026 U.S. stocks closed lower on Friday, with major indices posting declines amid broad market weakness. The Dow Jones Industrial Average fell 0.79%, the S&P 500 lost 0.71%, and the Nasdaq Composite dropped 1.03%. Among the hardest-hit sectors were crypto-linked stocks, which saw significant losses as… - [Novavax says partners got Nuvaxovid formulation approval](https://www.ainvest.com/news/novavax-partners-nuvaxovid-formulation-approval-2608) — AInvest Wire, Aug 28, 2026 Novavax Inc. announced that its partners have received regulatory approval for the updated formulation of its Nuvaxovid™ COVID-19 vaccine, designed for the 2025–2026 season . The approval marks a key milestone in the company’s strategy to provide a protein-based alternative to mRNA vaccines in the… ## Similar Stocks - [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock - [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock - [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock - [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares - [OCGN](https://www.lighthorse.io/tickers/ocgn) — Ocugen, Inc. - Common Stock --- Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express. This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness. Data provided by [AInvest](https://www.ainvest.com).